132 related articles for article (PubMed ID: 15864232)
1. Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial.
Smith CS; Cannon CP; McCabe CH; Murphy SA; Bentley J; Braunwald E
Am Heart J; 2005 Mar; 149(3):444-50. PubMed ID: 15864232
[TBL] [Abstract][Full Text] [Related]
2. Statins are associated with lower risk of gastrointestinal bleeding in patients with unstable coronary syndromes: analysis of the Orbofiban in Patients with Unstable coronary Syndromes-Thrombolysis In Myocardial Infarction 16 (OPUS-TIMI 16) trial.
Atar S; Cannon CP; Murphy SA; Rosanio S; Uretsky BF; Birnbaum Y
Am Heart J; 2006 May; 151(5):976.e1-6. PubMed ID: 16644315
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
[TBL] [Abstract][Full Text] [Related]
4. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
Yan AT; Yan RT; Tan M; Huynh T; Soghrati K; Brunner LJ; DeYoung P; Fitchett DH; Langer A; Goodman SG;
Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
[TBL] [Abstract][Full Text] [Related]
5. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E
Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).
Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC
Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951
[TBL] [Abstract][Full Text] [Related]
7. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
[TBL] [Abstract][Full Text] [Related]
8. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
Smith EE; Cannon CP; Murphy S; Feske SK; Schwamm LH
Am Heart J; 2006 Feb; 151(2):338-44. PubMed ID: 16442896
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study.
Zhao SP; Peng DQ; Yu BL; Huo Y;
Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407
[TBL] [Abstract][Full Text] [Related]
11. Impact of briefly-assessed depression on secondary prevention outcomes after acute coronary syndrome: a one-year longitudinal survey.
McGee HM; Doyle F; Conroy RM; De La Harpe D; Shelley E
BMC Health Serv Res; 2006 Feb; 6():9. PubMed ID: 16476160
[TBL] [Abstract][Full Text] [Related]
12. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.
Ye X; Gross CR; Schommer J; Cline R; St Peter WL
Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593
[TBL] [Abstract][Full Text] [Related]
13. Computerized community cholesterol control (4C): meeting the challenge of secondary prevention.
Gilutz H; Novack L; Shvartzman P; Zelingher J; Bonneh DY; Henkin Y; Maislos M; Peleg R; Liss Z; Rabinowitz G; Vardy D; Zahger D; Ilia R; Leibermann N; Porath A
Isr Med Assoc J; 2009 Jan; 11(1):23-9. PubMed ID: 19344008
[TBL] [Abstract][Full Text] [Related]
14. [Early statin treatment in acute coronary syndrome. Is this evidence-based?].
Jensen LO; Hansen HS
Ugeskr Laeger; 2002 Jul; 164(27):3519-22. PubMed ID: 12116678
[TBL] [Abstract][Full Text] [Related]
15. Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes.
Kandzari DE; Roe MT; Chen AY; Lytle BL; Pollack CV; Harrington RA; Ohman EM; Gibler WB; Peterson ED
Am Heart J; 2005 Mar; 149(3):474-81. PubMed ID: 15864236
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study.
Macin SM; Perna ER; Farías EF; Franciosi V; Cialzeta JR; Brizuela M; Medina F; Tajer C; Doval H; Badaracco R
Am Heart J; 2005 Mar; 149(3):451-7. PubMed ID: 15864233
[TBL] [Abstract][Full Text] [Related]
17. Treatment gap in the use of lipid-lowering drug therapy in diabetes: a population-based study.
James P; Tan HH; MacAlpine R; Brennan G; Emslie-Smith A; Morris AD
Diabet Med; 2004 Oct; 21(10):1108-12. PubMed ID: 15384958
[TBL] [Abstract][Full Text] [Related]
18. Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE).
Froehlich JB; Mukherjee D; Avezum A; Budaj A; Kline-Rogers EM; López-Sendón J; Allegrone J; Eagle KA; Mehta RH; Goldberg RJ;
Am Heart J; 2006 May; 151(5):1123-8. PubMed ID: 16644349
[TBL] [Abstract][Full Text] [Related]
19. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel.
Chodick G; Shalev V; Gerber Y; Heymann AD; Silber H; Simah V; Kokia E
Clin Ther; 2008 Nov; 30(11):2167-79. PubMed ID: 19108805
[TBL] [Abstract][Full Text] [Related]
20. Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromes.
Lenderink T; Boersma E; Gitt AK; Zeymer U; Wallentin L; Van de Werf F; Hasdai D; Behar S; Simoons ML
Eur Heart J; 2006 Aug; 27(15):1799-804. PubMed ID: 16820364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
